dc.contributor
Institut Català de la Salut
dc.contributor
[Higuera M] Grup de Recerca de les Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Vargas-Accarino E, Bermúdez-Ramos M] Grup de Recerca de les Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. [Torrens M, Soriano-Varela A] Grup de Recerca de les Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Salcedo MT] Servei d’Anatomia Patològica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Spanish Biomedical Research Network Centre in Oncology (CIBERONC), Instituto de salud Carlos III, Madrid, Spain. Department of Medicine, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. [Mínguez B] Grup de Recerca de les Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Department of Medicine, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Torrens Buscató, Maria
dc.contributor.author
Bermúdez-Ramos, Maria
dc.contributor.author
Soriano, Agnès
dc.contributor.author
Higuera Urbano, Monica
dc.contributor.author
Vargas-Accarino, Elena
dc.contributor.author
Salcedo, Maria-Teresa
dc.contributor.author
Minguez, Beatriz
dc.date.accessioned
2025-05-03T13:42:54Z
dc.date.available
2025-05-03T13:42:54Z
dc.date.issued
2025-04-10T12:48:08Z
dc.date.issued
2025-04-10T12:48:08Z
dc.identifier
Higuera M, Vargas-Accarino E, Torrens M, Bermúdez-Ramos M, Soriano-Varela A, Salcedo MT, et al. Impact of zinc on hepatocellular carcinoma cell behavior and metallothionein expression: Insights from preclinical models. Biomed Pharmacother. 2025 Apr;185:117918.
dc.identifier
http://hdl.handle.net/11351/12936
dc.identifier
10.1016/j.biopha.2025.117918
dc.identifier.uri
http://hdl.handle.net/11351/12936
dc.description.abstract
Carcinoma hepatocel·lular; Zinc; Biomarcador
dc.description.abstract
Hepatocellular carcinoma; Zinc; Biomarker
dc.description.abstract
Carcinoma hepatocelular; Zinc; Biomarcador
dc.description.abstract
Background
Zinc (Zn) is an essential trace element involved in a wide variety of cellular processes and is vital for optimal liver function. Our objective was to elucidate the potential therapeutic role of Zn in hepatocellular carcinoma (HCC), the third leading cause of cancer-related death and the first cause of death in patients with cirrhosis.
Methods
The impact of Zn supplementation on proliferation, invasion, migration, cell cycle, and apoptosis was conducted on four HCC cell lines as well as in a xenograft mouse model of HCC from which tumor gene expression profiles were also analyzed. Gene deregulation and protein expression were validated in human HCC tissues. Finally, Zn and MT1 (Metallothionein 1) levels were quantified in plasma from patients with HCC.
Results
Zn supplementation significantly modulated proliferation, invasion, and migration in HCC cell lines and induced apoptosis in a dose-dependent manner. Although Zn did not exhibit a significant increase in survival, Zn supplementation significantly altered the expression of MT genes. Specifically, MT1G and MT1H expression were notably suppressed in HCC tissues from mice and these results were validated in human HCC samples. Overall, gene and protein MTs expression was significantly lower in HCC areas compared to adjacent liver tissue and plasma Zn levels exhibited substantial variation across different stages of the liver disease.
Conclusion
Zn supplementation influences key cellular behaviors in a dose-dependent manner and upregulates the expression of MT family genes, which may have tumor-suppressive properties, in vitro an in vivo models. Future research should investigate the prognostic implications of Zn supplementation as part of a comprehensive therapeutic strategy for HCC patients.
dc.description.abstract
This work has been funded by a research grant from Laboratorios Viñas. BM is supported by competitive funding by Instituto de Salud Carlos III (ISCIII) (PI18/00961 and PI21/00714) and co-funded by the European Union.
dc.format
application/pdf
dc.relation
Biomedicine & Pharmacotherapy;185
dc.relation
https://doi.org/10.1016/j.biopha.2025.117918
dc.relation
info:eu-repo/grantAgreement/ES/PE2017-2020/PI21%2F00714
dc.rights
Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Fetge - Càncer - Tractament
dc.subject
Rates (Animals de laboratori)
dc.subject
Zinc - Ús terapèutic
dc.subject
Metal·loproteïnes
dc.subject
CHEMICALS AND DRUGS::Inorganic Chemicals::Elements::Metals, Heavy::Zinc
dc.subject
Other subheadings::Other subheadings::/pharmacology
dc.subject
DISEASES::Neoplasms::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Liver Neoplasms::Carcinoma, Hepatocellular
dc.subject
Other subheadings::Other subheadings::Other subheadings::/drug therapy
dc.subject
ORGANISMS::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Eutheria::Rodentia::Muridae::Murinae::Mice
dc.subject
CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Metalloproteins::Metallothionein
dc.subject
COMPUESTOS QUÍMICOS Y DROGAS::compuestos inorgánicos::elementos::metales pesados::zinc
dc.subject
Otros calificadores::Otros calificadores::/farmacología
dc.subject
ENFERMEDADES::neoplasias::neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias hepáticas::carcinoma hepatocelular
dc.subject
Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia
dc.subject
ORGANISMOS::Eukaryota::animales::Chordata::vertebrados::mamíferos::Eutheria::Rodentia::Muridae::Murinae::ratones
dc.subject
COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::metaloproteínas::metalotioneína
dc.title
Impact of zinc on hepatocellular carcinoma cell behavior and metallothionein expression: Insights from preclinical models
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion